Belegt, nicht behauptet.

Compounding & Administration Transfer Device Comparison Using Potential Surrogate for NIOSH Protocol

Litmus Test Method for CSTD Dry Disconnection Validation

Evaluation of the effect of closed system transfer device syringe adaptor connection in the isolator on cytotoxic residue contamination during intravenous administration

Marie-Claude Gutekunst, MSN, RN, BCMAS, Akshar N. Patel, PharmD, RPH, Christopher R. Curtin, BS1, Kaisa Kivilaid, MS, Diana Valencia, MD

Evaluation of a Database Containing Pharmacy and Nursing Real-World Hazardous Drug Wipe Test Following Use of an Air-Cleaning Closed System Transfer Device (CSTD) to Assess Surface Contamination

Marie-Claude Gutekunst, MSN, RN, BCMAS, Akshar N. Patel, PharmD, RPH, Christopher R. Curtin, BS1, Kaisa Kivilaid, MS, Diana Valencia, MD

Hazardous Drug Locking Capacity of Activated Carbon-Based CSTD: 3 Approaches

Evaluation of long-term prevention of microbiological contamination of sterile preparations in a controlled ISO class 5 environment and an uncontrolled environment using a closed-system drug transfer device

Robert Terkola, MSc, PhD, aHPh, Chiara N. J. Pietrzak, Alexander S. Nebel, BSc

Accuracy and Sterility Performance of a New Pharmacy Robot-CSTD Combination

Karam Mansour, Oz Shriki, Nadir Haskiya, Ido Tomy, Elana A. Slutsky Smith

New Method for Assessment of Environmental Viral Contamination of Liquids Prepared in Closed-System Drug Transfer Devices

Maya Amichay, Elana A. Slutsky Smith

Chemfort® Protects Against Bacterial Contamination for 7 Days

Integrity Performance Assessment of a Closed System Transfer Device Syringe Adaptor as a Terminal Closure for Luer-Lock Syringes

Chemfort® Compatibility With All Known Hazardous Drugs

Studies on the stability and compatibility of cytotoxic drug infusions with the Tevadaptor device

Professor Graham Sewell, PhD; Milena Massimini. EJOP, Volume 8, Issue 3, 2014

Safe Handling of Monoclonal Antibody-based Drugs (mABs)

Die NIOSH-Liste gefährlicher Arzneimittel aus dem Jahr 2016 umfasst vier mABs. Die wiederholte Exposition von medizinischem Fachpersonal gegenüber gef

Economic Impact of Closed Systems Transfer Devices in the Cytotoxic Preparation Unit at Hospital Do Espirito Santo, Evora

F. Fonseca, A. Rosa, G. Caine, M. Pereira, N. Landeira

Responding to drug shortages and rising costs: IV chemotherapy drug use

Ákos Juhász, Gábor Batka & Attila Szűcs, Drugs Ther Perspect (2016) 32:170-176 DOI 10.1007/s40267-016-0285-6

Head-to-head evaluation of closed-system transfer devices in a health-system oncology clinic

M. Jay Brown, PharmD, BCOP, Rolanda Davis-Lowery, BA, CPhT; Novant Health Forsyth Medical Center - Department of Pharmacy.

Implementing a Closed System Drug-Transfer Device to Enable Nurses to Prepare Monoclonal Antibody Treatment

Büchelstrasse 5-7, 66538 Neunkirchen

Comparative Study of the Different Closed System Transfer Devices Available in France for the Preparation of Injectable Immunotherapies

Büchelstrasse 5-7, 66538 Neunkirchen